Reddit Posts
Feetr Data Dump: SQL PACW BIOC OMH AUVI CWBR OCEA
Biocept [BIOC], Biopharma with good benefits and SS potential
NALL you should resign RIGHT NOW
NALL you must resign RIGHT NOW
BIOC. Biocept nasdaq. To the Moon🚀 Market Cap 64M. Q3 17.5M 🚀
✅ BIOC ✅ Biocept nasdaq. 🚀🚀🚀🚀 Market Cap 64M. Q3 17.5M
✅ BIOC ✅ Biocept nasdaq. Too the Moon🚀 Market Cap 64M. Q3 17.5M 🚀
✅ BIOC ✅ Biocept nasdaq. To the moon 🚀 Market Cap 64M. Q3 17.5M
BIOC Biocept nasdaq. Market Cap 64M. Q3 17.5M
✅ BIOC ✅ Short Squeeze ⚠️ YOLO. 🚀🚀🚀🚀 70-90% Dark Pool‼ ️day to day.
BIOC Biocept Bomb Share!On Thursday 19 opened 17 million in additional short shares, on a float of 13 million. Squeeze imminent!
$BIOC Bomb Stock! On Thursday 19 opened 17 million in additional short shares, on a float of 13 million. Squeeze Imminent!
12x increase unusual volume on BIOC after news of Medicare Coverage of Biocept's breast cancer diagnostic test, 13 million float, eps .19 high, currently trading at $4.10
BIOC selling the news not in line with its potential on latest developements
BIOC Biocept DD seems perfect to get in now
$BIOC was a stock over $9k per share in 2014, now at $4.80. This seems crazy low right now
Mentions
Invest in an emerging hedge fund. Look at BIOC:NASDAQ. 08-Sep, released, 8AM news and up 60% in 20min.
Check out the stock BIOC:NASDAQ. If you look at the chart from pre-market @ 8AM, they released news. Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics by 9:30AM, they were up 100% I'm starting a hedge fund incubator and would love to chat.
I’m not too sure yet. Obviously they are diluting. I think they are already at 50-100M shares diluted, but if not, AMC is in a lot more trouble than originally expected. I sold 6k worth of puts on Wednesday, added 5k today. My puts I want to sell between 3-5, so I don’t really look at day to day too much. I added more today because my other stocks I wanted to trade were not following what I wanted. Wanted to short BIOC, but I didn’t understand fees and all of that, would’ve made about 2k if I had known.
I am a bot. You submitted a picture of a banned ticker, BIOC. The market cap of BIOC is **9,126,440** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: BIOC. Message /u/zjz if they're above 500 million-ish market cap and not related to crypto/pennies/OTC.
Why don't we invest in a penny stock with little float? Something like BIOC which is tremendously shortened. In August shorts were opened tripling the float in two hours
Good luck went through this with BIOC and when they didn't get enough yes for dilution they extended the vote until they got it
BIOC is the best candidate for short squeeze and it’s a good company with more cash on hand than market cap. Covid revenue to pay the bills for while and the core business is to detect cancer trough blood. Quest diagnostics is selling their test for lung cancer and a second one for breast cancer to be introduced this year. There are much more synthetic short shares than the total share count. If you look 8/19/2021 the entire stock volume was traded 4 times in one hour. There are not enough shares for the shorts to cover.
The next big squeeze will be BIOC
Guys check out $BIOC cash on hand more than the market cap. They detect cancer trough blood and have big contracts with Quest diagnostics and TRIcare. For the last year they have been doing Covid testing. Highly manipulated stock, more shorts than the actual available shares. The squeeze will be epic, it’s a good profitable company with a lot of potential.
accumulated massive position in BIOC .. it will be make or break for me. I have been dreaming for 10x and retirement :) COH > market cap
BIOC … holding for a few years now. Multiple reverse splits, shorted and manipulated stock. Good company currently at 52 weeks low, cash on hand close to the only 50 million market cap. Great 10x potential. Detects cancer trough blood. Currently doing Covid testing as well to help pay for future research
BIOC hits another 52 weeks low … what a surprise ……
Record breaking q4 revenue due to covid testing, Quest diagnostic started selling their liquid biopsies assays in early December at 2500$ per test. A few other contracts that will bring additional revenue. BIOC is Potential buyout target due to core oncology business and patents. A short squeeze candidate due to many synthetic short shares and small float.
BIOC … highly manipulated stock it has been shorted like crazy. Currently at 52 weeks low. Cash on hand close to the market cap. Low float it will skyrocket very soon.
>presa de servicios de laboratorio de oncología centrada en el desarrollo y comercialización de nuevos BIOC is going to explode, on the way to squeeze, it is camouflaged by the data that was not declared in Q3, it will do it in Q4 together with the high value contracts. Every quarter a new record, this year is going to close with 200% growth. It has half in cash, is in profit and this quarter it brought its contracts into production for the first time with a 1 billion annual market in the U.S. alone. Pools daily at 85%, the best time for a big squeeze, it is in profit, even having moved revenues from Q3 to Q4, so this quarter it will break all records. BIOC is growing 200% y/y, not counting the high value contracts that started in Q4, and are expected in the report, which will add much more.
BIOC is second in the 2022 first squeezee rankings, despite being a small of only 55 million, half in cash. It is at the best time for a big squeeze, in profit even having carried over revenue from Q3 to Q4. BIOC is growing 200% YoY and in Q4 for the first time billed high value contracts. Vote poll: https://strawpoll.com/3e333csjg
You must explain how can be that $BIOC capitalizes only 65M with contracts with Quest and Medicare for more than 1B. Why you haven't said a word about this. Why you haven't said a word about the thousands of Covid tests $BIOC has performed. Why you have moved the earnings of the Covid tests to Q1 of 2022. Why they dark poolsin $BIOC are over 75-80% as a regular basis. Why they opened 17M shorts in one day with just 13M free float... Why you don't show any respect to the shareholders.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: BIOC. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: BIOC. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
$BIOC on [https://www.prnewswire.com/news-releases/quest-diagnostics-now-offers-biocepts-liquid-biopsy-test-for-lung-cancer-expanding-its-menu-of-advanced-cancer-diagnostics-301435081.html](https://www.prnewswire.com/news-releases/quest-diagnostics-now-offers-biocepts-liquid-biopsy-test-for-lung-cancer-expanding-its-menu-of-advanced-cancer-diagnostics-301435081.html)
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: BIOC. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
Buying Plug Power for $2.3 and selling for $71.0. Other hydrogen successes where Nel ASA and PowerCell Sweden. Now most of my money is in $BIOC, if my DD is right this will be a giant succes.
$BIOC launches first combined Covid19 and Influenza [test](https://www.businesswire.com/news/home/20211122005908/en/Biocept-Launches-Combined-COVID-19-and-Influenza-Test-to-Provide-Answers-During-Peak-Flu-Season/?feedref=JjAwJuNHiystnCoBq_hl-bV7DTIYheT0D-1vT4_bKFzt_EW40VMdK6eG-WLfRGUE1fJraLPL1g6AeUGJlCTYs7Oafol48Kkc8KJgZoTHgMu0w8LYSbRdYOj2VdwnuKwa&s3=BIOC/2021-11-22/08-22-42_000000/bw/a2c06df68cacc2fcb372cc2da8c956b6/Biocept-Launches-Combined-COVID-19-and-Influenza-Test-to-Provide-Answers-During-Peak-Flu-Season.html) through TMO platform.
$BIOC will have Q3 earnings and positive EPS results in after hours
BIOC. Undervalued Cancer diagnostics company. P/B and P/S under 2.
That sounds like it’s straight from their website... I’ve lost $1000s on BioTech companies all claiming the same thing... “we are approved in this country and that country, we are guaranteed approval in the US!” Unfortunately that is rarely the case... check out all of the old news from BIOC and VTGN, same things but after dropping under $1 countless times and doing many reverse splits they are still saying that it will be approved 🙄 Good luck with that one!
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: BIOC. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: BIOC. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: BIOC. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.
I thought so too, I sold all this morning and bought BIOC and day traded that
BIOC had good news on their CNSide product today, heavy shorting though
BIOC good news on CNSide today, heavy shorting
Biocept (BIOC) in the Run🚀
I think BIOC recovers. ER and outlook were both solid. Weak hands shaken out. With market cap under $50M and share count under $14M, this is poised to soar!
BIOC on positive EPS, revenue increase, Covid testing and cancer liquid biopsy progress.
BIOC on good Covid revenue and sales progression in cancer liquid biopsy.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: BIOC. Message /u/zjz if they're above 1.25 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.
BIOC [Selling the news](https://finance.yahoo.com/news/biocept-collaborate-quest-diagnostics-advanced-121700201.html) and shorting becomes really annoying on this stock. There is [so much](https://finance.yahoo.com/news/biocept-receives-more-420-000-121700515.html)great [potential](https://finance.yahoo.com/news/biocept-reports-first-quarter-2021-200500571.html)in all the last [news articles](https://finance.yahoo.com/news/biocept-announces-full-commercial-launch-121700635.html). The low float makes it easy to push the manipulation out, but we lack buyers. Come over it has great ER en new contracts.
BIOC on [https://finance.yahoo.com/news/biocept-collaborate-quest-diagnostics-advanced-121700201.html](https://finance.yahoo.com/news/biocept-collaborate-quest-diagnostics-advanced-121700201.html)
BIOC releases news [https://finance.yahoo.com/news/biocept-receives-more-420-000-121700515.html](https://finance.yahoo.com/news/biocept-receives-more-420-000-121700515.html) more then 420.000 covid samples received. 3th quarter in a row with profitable EPS. Great things just started such as liquid biopsy product CNside among others. 13M shares outstanding with limited available. Come for a play today.
I’m surprised people haven’t caught on to BIOC yet.
BIOC will leave pennyland today. pre-market 4.93 +0.41 (9.07%) news on liquid biopsy later today, early morning news on covid testing and profitable for third quarter in a row.
BIOC will leave pennyland today. pre-market 4.93 +0.41 (9.07%)
News next week june the 9th. L2 almost nothing with share shortage for buyers. “We look forward to providing investors with an update on CNSide™, our novel assay that provides physicians with a significantly improved tool to diagnose and manage patients with tumors that have metastasized to the central nervous system,” said Mr. Nall. “CNSide’s full commercial launch is now underway with the potential to provide critical information for the approximately 200,000 patients in the U.S. each year who have progression of their cancer to the central nervous system.” https://www.stocktitan.net/news/BIOC/biocept-to-present-at-the-ld-micro-virtual-invitational-xi-0ufytfenboyx.html
Bravo! Thank you. I'm a believer in BIOC too.
https://www.stocktitan.net/news/BIOC/biocept-reports-first-quarter-2021-financial-gx2kn8r19szl.html#
https://www.stocktitan.net/news/BIOC/biocept-reports-first-quarter-2021-financial-gx2kn8r19szl.html#
I'm bullish on BIOC if anyone has ever heard of it...
I am a bot. You submitted a picture of a banned ticker, BIOC. Yell at /u/zjz if it's above 1 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.
BIOC has good q1 ER the 12th
$BIOC could get a small boost with their current partnership with the foundation of California Community Colleges to supply COVID-19 testing. Worth checking out IMO.
I feel like except for this past week, BIOC hasn't been doing so well but I could be wrong
BIOC is a great play for the comming weeks. A new product [launched last week CNSide](https://finance.yahoo.com/news/biocept-announces-full-commercial-launch-121700635.html), with great backup by clinical facilities. A new Covid testing contract for [California](https://finance.yahoo.com/news/biocept-supply-covid-19-testing-121700224.html) announced today that provides good income. They had a [profitable q4](https://finance.yahoo.com/news/biocept-reports-2020-fourth-quarter-200500349.html)2020 and moved to a new facility that cut cost by 20%. Q1 ER will be even better. Still a pennystock, this pharma will transcend from research and development into sales very quickly. With its Low float of 13M I think one of the best plays to get into now.
ROM, SRNE, BIOC, HTBX, OGI all up today without any news or other catalysts.
This is the ground floor for BIOC. I’ve been watching for 14 months and something BIG is about to happen. 🚀
BIOC saving the fuckin day
I am a bot. You submitted a picture of a banned ticker, BIOC. Yell at /u/zjz if it's above 1 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.
This post mentions: **$BIOC** /u/jdathescore's account was created **4 years ago**. It has **2077** comment karma and **7130** link karma. ----- ^You ^may ^see ^tickers ^you ^didn't ^mention ^-- ^I'm ^casting ^a ^wide ^net ^because ^y'all ^don't ^always ^$TAG ^your ^ticker ^symbols. ^This ^was ^an ^automated ^response. ^If ^you ^have ^feedback, ^please ^reply ^to ^this ^comment ^or [^(send me a message)](https://www.reddit.com/message/compose?to=RichSteps&subject=bot%20feedback)^.
ITM calls on $BIOC seem to work
Just bought BIOC as I'm liking the post earnings price action. Other than that I'm flat selling premium or buying a bit of premium for bearish spreads. Mostly cash as this market is very uncertain.
BIOC mooning before the earnings call in a little bit.
Smartest move I did all day sold my RKT and put it into BIOC right before close wow that worked out ❤️
BIOC and OI you will make money
#BIOC was one worth 8.5K a share jesus what happened lol
My English is not good, the content is too much, the following is machine translation: Hello everyone, I am from China. Today I will share a stock with you, not investment advice. The stock is called BIOC, a cancer diagnostic company that focuses on the development and sales of proprietary blood sample tests. I like this stock based on the following two considerations, please don't miss it when you pass by. 1. Although this stock has been declining for a long time, it has even fallen into gross votes, its performance has been sluggish for a long time, and it has been at a loss. However, last year, due to the new crown epidemic, it began to attract attention, and during the period, it has exploded several times intermittently. In the two days when the third quarter financial report was announced on November 12, 2020, the stock price rose by 30%. If you carefully study the financial report, you will find that the operating income in the third quarter was 6,586,100 yuan, a year-on-year increase of 330%. This is only one quarter's revenue. You must know that the company's operating revenue in 2019 is only 5.5286 million yuan. The current total operating income for the first three quarters is about 8.95 million yuan. Why did the operating income suddenly increase like this? It turned out that the company started to operate a new business in August 2020, testing COVID-19 samples. For each sample tested, the government subsidized 100 US dollars, so operating income skyrocketed. . The following are the relevant data: 7000 samples were announced on August 3, 2020, 21000 samples were received on August 31, 35000 samples were received on September 16, and 35000 samples were announced on October 29. To 80,000 samples, it was announced on November 12 that it had received 100,000 samples (the financial report was announced at this time, and the revenue in the first three quarters had reached 8.95 million yuan), and it was announced on December 14 that it had received 150,000 samples. It was announced on February 3, 2021 that 250,000 samples had been received. Therefore, the key point is that based on the number of samples tested above, in the next annual report to be published on March 24, 2021, I predict that operating income will increase (150,000-100000) X 100 US dollars = 5 million income. In other words, the total income in 2020 will be at least 8.95 million + 5 million, and there will be at least 14 million in income, which is an increase of 153% relative to the income in 2019! In the two days when the financial report was announced on March 24, I hope to see the stock price also double. The above is based on the view of the financial report, let's talk about this company. 2. Due to the raging new crown epidemic, this testing business is expected to continue for a long time, and Cathie Wood once mentioned that her fund company will focus on cancer testing companies in the next step (you can find this information yourself). Therefore, I am very optimistic about the prospects of this company. Writing these words in a hurry during working hours is not investment advice. Please criticize and correct me.
My English is not good, the content is too much, the following is machine translation: Hello everyone, I am from China. Today I will share a stock with you, not investment advice. The stock is called BIOC, a cancer diagnostic company that focuses on the development and sales of proprietary blood sample tests. I like this stock based on the following two considerations, please don't miss it when you pass by. 1. Although this stock has been declining for a long time, it has even fallen into gross votes, its performance has been sluggish for a long time, and it has been at a loss. However, last year, due to the new crown epidemic, it began to attract attention, and during the period, it has exploded several times intermittently. In the two days when the third quarter financial report was announced on November 12, 2020, the stock price rose by 30%. If you carefully study the financial report, you will find that the operating income in the third quarter was 6,586,100 yuan, a year-on-year increase of 330%. This is only one quarter's revenue. You must know that the company's operating revenue in 2019 is only 5.5286 million yuan. The current total operating income for the first three quarters is about 8.95 million yuan. Why did the operating income suddenly increase like this? It turned out that the company started to operate a new business in August 2020, testing COVID-19 samples. For each sample tested, the government subsidized 100 US dollars, so operating income skyrocketed. . The following are the relevant data: 7000 samples were announced on August 3, 2020, 21000 samples were received on August 31, 35000 samples were received on September 16, and 35000 samples were announced on October 29. To 80,000 samples, it was announced on November 12 that it had received 100,000 samples (the financial report was announced at this time, and the revenue in the first three quarters had reached 8.95 million yuan), and it was announced on December 14 that it had received 150,000 samples. It was announced on February 3, 2021 that 250,000 samples had been received. Therefore, the key point is that based on the number of samples tested above, in the next annual report to be published on March 24, 2021, I predict that operating income will increase (150,000-100000) X 100 US dollars = 5 million income. In other words, the total income in 2020 will be at least 8.95 million + 5 million, and there will be at least 14 million in income, which is an increase of 153% relative to the income in 2019! In the two days when the financial report was announced on March 24, I hope to see the stock price also double. The above is based on the view of the financial report, let's talk about this company. 2. Due to the raging new crown epidemic, this testing business is expected to continue for a long time, and Cathie Wood once mentioned that her fund company will focus on cancer testing companies in the next step (you can find this information yourself). Therefore, I am very optimistic about the prospects of this company. Writing these words in a hurry during working hours is not investment advice. Please criticize and correct me.
My English is not good, the content is too much, the following is machine translation: Hello everyone, I am from China. Today I will share a stock with you, not investment advice. The stock is called BIOC, a cancer diagnostic company that focuses on the development and sales of proprietary blood sample tests. I like this stock based on the following two considerations, please don't miss it when you pass by. 1. Although this stock has been declining for a long time, it has even fallen into gross votes, its performance has been sluggish for a long time, and it has been at a loss. However, last year, due to the new crown epidemic, it began to attract attention, and during the period, it has exploded several times intermittently. In the two days when the third quarter financial report was announced on November 12, 2020, the stock price rose by 30%. If you carefully study the financial report, you will find that the operating income in the third quarter was 6,586,100 yuan, a year-on-year increase of 330%. This is only one quarter's revenue. You must know that the company's operating revenue in 2019 is only 5.5286 million yuan. The current total operating income for the first three quarters is about 8.95 million yuan. Why did the operating income suddenly increase like this? It turned out that the company started to operate a new business in August 2020, testing COVID-19 samples. For each sample tested, the government subsidized 100 US dollars, so operating income skyrocketed. . The following are the relevant data: 7000 samples were announced on August 3, 2020, 21000 samples were received on August 31, 35000 samples were received on September 16, and 35000 samples were announced on October 29. To 80,000 samples, it was announced on November 12 that it had received 100,000 samples (the financial report was announced at this time, and the revenue in the first three quarters had reached 8.95 million yuan), and it was announced on December 14 that it had received 150,000 samples. It was announced on February 3, 2021 that 250,000 samples had been received. Therefore, the key point is that based on the number of samples tested above, in the next annual report to be published on March 24, 2021, I predict that operating income will increase (150,000-100000) X 100 US dollars = 5 million income. In other words, the total income in 2020 will be at least 8.95 million + 5 million, and there will be at least 14 million in income, which is an increase of 153% relative to the income in 2019! In the two days when the financial report was announced on March 24, I hope to see the stock price also double. The above is based on the view of the financial report, let's talk about this company. 2. Due to the raging new crown epidemic, this testing business is expected to continue for a long time, and Cathie Wood once mentioned that her fund company will focus on cancer testing companies in the next step (you can find this information yourself). Therefore, I am very optimistic about the prospects of this company. Writing these words in a hurry during working hours is not investment advice. Please criticize and correct me.
This post mentions: **$BIOC** /u/chungege's account was created **1 month ago**. It has **17** comment karma and **43** link karma. ----- ^You ^may ^see ^tickers ^you ^didn't ^mention ^-- ^I'm ^casting ^a ^wide ^net ^because ^y'all ^don't ^always ^$TAG ^your ^ticker ^symbols. ^This ^was ^an ^automated ^response. ^If ^you ^have ^feedback, ^please ^reply ^to ^this ^comment ^or [^(send me a message)](https://www.reddit.com/message/compose?to=RichSteps&subject=bot%20feedback)^.
I just read an article that has biocept (BIOC)at a price target of $20. It's like $6 now..earnings come out March 31..I WONDER???
Anybody looking at BIOC these days?
Well I bought NVIV, BIOC, and DFFN on Tuesday (at a goddamn high of course) and currently down 12%....but I’m gonna ride this wave. And hope for the best next week. Am I crazy on holding these 3 stocks?
I bought $DFFN $NVIV and $BIOC on Tuesday (at a high of course). I’m starting to regret a lot of major life decisions. Should I just ride it out? Already down $1,500
No joke, I bought DFFN, BIOC, and NVIV yesterday to do exactly that, diversification. Terrible timing